MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Current Options for Mitral Annuloplasty and Leaflet Repair
The benefits and limitations of today's FDA- and CE Mark–approved mitral repair technologies.
By Robert Schueler, MD, and Jan-Malte Sinning, MD, FESC
Philips Launches IntraSight Plus Interventional Guidance Platform
March 30, 2026—Royal Philips announced the launch of the IntraSight Plus interventional guidance platform, which has received FDA 510(k) clearance in the United States and CE Mark approval Europe.
Mitral & Tricuspid Transcatheter Therapies
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD
Published Studies Focus on TAVI
November 22, 2010—Transcatheter aortic valve implantation (TAVI) is the focus of the current issue of the Journal of the American College of Cardiology: Cardiovascular Interventions, in which Martyn Thomas, MD, reviewed the global experience with percutaneous aortic valve replacement (2010;3:1103–1109).
